Notes to the Group Annual Financial Statements – Note 10

10. Investment in subsidiaries
 
  Company
  June 2018
R’000		   June 2017
R’000
Unlisted investments at cost 428 144   428 144

Name Main business Country of
incorporation		 Interest held
(voting rights)
%		 Non-
controlling
interest
(voting rights)
%		  
2018 and 2017          
Directly held          
AfroCentric Resources Proprietary Limited Dormant South Africa 100 –  
AfroCentric Capital Proprietary Limited Dormant South Africa 100 –  
ACT Healthcare Assets Proprietary Limited Investment holding South Africa 71.3 28.7  
ACT Funding Proprietary Limited Dormant South Africa 100 –  
Indirectly held          
AfroCentric Health Proprietary Limited Healthcare administration South Africa 71.3 28.7  

The indirectly held subsidiary, Medscheme Holdings Proprietary Limited owned by AfroCentric Health Proprietary Limited, operates in the healthcare administration industry and is a subsidiary that has non-controlling interests that are material to the Group. The total aggregate assets, liabilities and results of Medscheme Holdings Proprietary Limited operations are summarised as follows:

Summarised statement of financial position of Medscheme Holdings Proprietary Limited

  Group  
  June 2018
R’000		   June 2017
R’000		  
Non-current assets (excluding intangible assets) 152 017   158 491  
Intangible assets 4 952   18 777  
Current assets 913 469   950 271  
Total assets 1 070 438   1 127 539  
Non-current liabilities 25 644   27 850  
Current liabilities 205 896   235 681  
Total liabilities 231 540   263 531  

Summarised statement of comprehensive income of Medscheme Holdings Proprietary Limited

  Group
  June 2018 
R’000 		   June 2017 
R’000 
Revenue 2 159 120    2 008 106 
Profit for the period 143 130    216 194 
Other comprehensive loss (128)   (285)
Total comprehensive income 143 002    215 909 

Summarised statement of cash flows of Medscheme Holdings Proprietary Limited

  Group
  June 2018 
R’000 		   June 2017 
R’000 
Net cash inflow from operating activities (2 835)   309 744 
Net cash outflow from investing activities (2 013)   (188 432)
Net cash inflow from financing activities (157 453)   1 234 
Net increase/(decrease) in cash and cash equivalents (162 301)   (122 546)

Notes to the Group Annual Financial Statements – Note 10